- Home
- WVE vs ALM Comparison
WVE vs ALM Comparison
Compare WVE & ALM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WVE
- ALM
- Stock Information
- Founded
- WVE 2012
- ALM N/A
- Country
- WVE Singapore
- ALM Canada
- Employees
- WVE N/A
- ALM N/A
- Industry
- WVE Biotechnology: Pharmaceutical Preparations
- ALM Other Metals and Minerals
- Sector
- WVE Health Care
- ALM Basic Materials
- Exchange
- WVE Nasdaq
- ALM Nasdaq
- Market Cap
- WVE 915.6M
- ALM 958.4M
- IPO Year
- WVE 2015
- ALM N/A
- Fundamental
- Price
- WVE $6.97
- ALM $4.46
- Analyst Decision
- WVE Strong Buy
- ALM Strong Buy
- Analyst Count
- WVE 17
- ALM 2
- Target Price
- WVE $19.94
- ALM $7.00
- AVG Volume (30 Days)
- WVE 2.4M
- ALM 695.4K
- Earning Date
- WVE 11-11-2025
- ALM 08-14-2025
- Dividend Yield
- WVE N/A
- ALM N/A
- EPS Growth
- WVE N/A
- ALM N/A
- EPS
- WVE N/A
- ALM N/A
- Revenue
- WVE $93,946,000.00
- ALM $20,657,545.00
- Revenue This Year
- WVE N/A
- ALM $143.16
- Revenue Next Year
- WVE $10.02
- ALM $126.76
- P/E Ratio
- WVE N/A
- ALM N/A
- Revenue Growth
- WVE N/A
- ALM 9.87
- 52 Week Low
- WVE $5.28
- ALM $3.16
- 52 Week High
- WVE $16.74
- ALM $5.50
- Technical
- Relative Strength Index (RSI)
- WVE 29.71
- ALM 51.41
- Support Level
- WVE $7.12
- ALM $3.98
- Resistance Level
- WVE $7.76
- ALM $4.63
- Average True Range (ATR)
- WVE 0.51
- ALM 0.28
- MACD
- WVE -0.32
- ALM 0.04
- Stochastic Oscillator
- WVE 0.57
- ALM 69.24
About WVE Wave Life Sciences Ltd.
WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
About ALM Almonty Industries Inc. Common Shares
Almonty Industries Inc is engaged in the mining, processing, and shipping of tungsten concentrate from its Los Santos tungsten mine located near Salamanca, Spain - the Los Santos Mine, the processing and shipping of tungsten concentrate from its Panasqueira tin and tungsten mine in Covilha, Castelo Branco, Portugal - the Panasqueira Mine, the evaluation of its Valtreixal tin and tungsten mine project located in Western Spain in the province of Zamora - the Valtreixal Mine, as well as the exploration and evaluation of its Sangdong tungsten mine project located in Gangwon Province, Republic of Korea - the Sangdong Mine.